Jake Leach became DexCom’s chief executive on January 1 and is trying to write the turnaround story of this innovative medtech company. One story to tell is how CGMs should be a no-brainer for type 2 diabetes patients on GLP-1 weight loss drugs.
The post DexCom’s CEO Believes Diabetics On GLP-1s Should Also Wear CGMs appeared first on MedCity News.
